Literature DB >> 20173743

Myc-modulated miR-9 makes more metastases.

Yeesim Khew-Goodall1, Gregory J Goodall.   

Abstract

The microRNA miR-9 is induced by Myc in breast cancer cells where it targets the major epithelial adherens junction protein, E-cadherin. This primes the cancer cells for epithelial-mesenchymal transition (EMT) and also stimulates angiogenesis in tumours.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20173743     DOI: 10.1038/ncb0310-209

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.824


  13 in total

1.  MicroRNA-9 directs late organizer activity of the midbrain-hindbrain boundary.

Authors:  Christoph Leucht; Christian Stigloher; Andrea Wizenmann; Ruth Klafke; Anja Folchert; Laure Bally-Cuif
Journal:  Nat Neurosci       Date:  2008-05-04       Impact factor: 24.884

2.  Identification of c-MYC as a target of the APC pathway.

Authors:  T C He; A B Sparks; C Rago; H Hermeking; L Zawel; L T da Costa; P J Morin; B Vogelstein; K W Kinzler
Journal:  Science       Date:  1998-09-04       Impact factor: 47.728

3.  miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis.

Authors:  Li Ma; Jennifer Young; Harsha Prabhala; Elizabeth Pan; Pieter Mestdagh; Daniel Muth; Julie Teruya-Feldstein; Ferenc Reinhardt; Tamer T Onder; Scott Valastyan; Frank Westermann; Frank Speleman; Jo Vandesompele; Robert A Weinberg
Journal:  Nat Cell Biol       Date:  2010-02-21       Impact factor: 28.824

4.  MicroRNA-21 targets tumor suppressor genes in invasion and metastasis.

Authors:  Shuomin Zhu; Hailong Wu; Fangting Wu; Daotai Nie; Shijie Sheng; Yin-Yuan Mo
Journal:  Cell Res       Date:  2008-03       Impact factor: 25.617

5.  Tumour invasion and metastasis initiated by microRNA-10b in breast cancer.

Authors:  Li Ma; Julie Teruya-Feldstein; Robert A Weinberg
Journal:  Nature       Date:  2007-09-26       Impact factor: 49.962

6.  Contextual extracellular cues promote tumor cell EMT and metastasis by regulating miR-200 family expression.

Authors:  Don L Gibbons; Wei Lin; Chad J Creighton; Zain H Rizvi; Philip A Gregory; Gregory J Goodall; Nishan Thilaganathan; Liqin Du; Yiqun Zhang; Alexander Pertsemlidis; Jonathan M Kurie
Journal:  Genes Dev       Date:  2009-09-15       Impact factor: 11.361

Review 7.  Bench to bedside and back again: molecular mechanisms of alpha-catenin function and roles in tumorigenesis.

Authors:  Jacqueline M Benjamin; W James Nelson
Journal:  Semin Cancer Biol       Date:  2007-09-04       Impact factor: 15.707

8.  The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis.

Authors:  Qihong Huang; Kiranmai Gumireddy; Mariette Schrier; Carlos le Sage; Remco Nagel; Suresh Nair; David A Egan; Anping Li; Guanghua Huang; Andres J Klein-Szanto; Phyllis A Gimotty; Dionyssios Katsaros; George Coukos; Lin Zhang; Ellen Puré; Reuven Agami
Journal:  Nat Cell Biol       Date:  2008-01-13       Impact factor: 28.824

9.  Expression profile of microRNAs in c-Myc induced mouse mammary tumors.

Authors:  Yuan Sun; Jack Wu; Si-hung Wu; Archana Thakur; Aliccia Bollig; Yong Huang; D Joshua Liao
Journal:  Breast Cancer Res Treat       Date:  2008-09-07       Impact factor: 4.872

10.  Endogenous human microRNAs that suppress breast cancer metastasis.

Authors:  Sohail F Tavazoie; Claudio Alarcón; Thordur Oskarsson; David Padua; Qiongqing Wang; Paula D Bos; William L Gerald; Joan Massagué
Journal:  Nature       Date:  2008-01-10       Impact factor: 49.962

View more
  51 in total

1.  Aberrant hypermethylation of miR-9 genes in gastric cancer.

Authors:  Kuo-Wang Tsai; Yu-Lun Liao; Chew-Wun Wu; Ling-Yueh Hu; Sung-Chou Li; Wen-Ching Chan; Meng-Ru Ho; Chun-Hung Lai; Hsiao-Wei Kao; Wen-Liang Fang; Kuo-Hung Huang; Wen-chang Lin
Journal:  Epigenetics       Date:  2011-10-01       Impact factor: 4.528

2.  A novel saliva-based microRNA biomarker panel to detect head and neck cancers.

Authors:  Carolina Salazar; Rahul Nagadia; Pratibala Pandit; Justin Cooper-White; Nilanjana Banerjee; Nevenka Dimitrova; William B Coman; Chamindie Punyadeera
Journal:  Cell Oncol (Dordr)       Date:  2014-08-26       Impact factor: 6.730

3.  MicroRNA-9 as a novel prognostic biomarker in human laryngeal squamous cell carcinoma.

Authors:  Shuo Wu; Shenshan Jia; Ping Xu
Journal:  Int J Clin Exp Med       Date:  2014-12-15

4.  MicroRNA-9 promotes tumorigenesis and mediates sensitivity to cisplatin in primary epithelial ovarian cancer cells.

Authors:  Hong-Min Zhao; Wei Wei; Yu-Hui Sun; Jian-Hua Gao; Qi Wang; Jian-Hua Zheng
Journal:  Tumour Biol       Date:  2015-04-07

Review 5.  Generation of cardiac progenitor cells through epicardial to mesenchymal transition.

Authors:  Antonia Germani; Eleonora Foglio; Maurizio C Capogrossi; Matteo Antonio Russo; Federica Limana
Journal:  J Mol Med (Berl)       Date:  2015-05-07       Impact factor: 4.599

Review 6.  Metastatic bone disease: role of transcription factors and future targets.

Authors:  Jitesh Pratap; Jane B Lian; Gary S Stein
Journal:  Bone       Date:  2010-06-01       Impact factor: 4.398

7.  MiR-9, -31, and -182 deregulation promote proliferation and tumor cell survival in colon cancer.

Authors:  Lina Cekaite; Juha K Rantala; Jarle Bruun; Marianne Guriby; Trude H Agesen; Stine A Danielsen; Guro E Lind; Arild Nesbakken; Olli Kallioniemi; Ragnhild A Lothe; Rolf I Skotheim
Journal:  Neoplasia       Date:  2012-09       Impact factor: 5.715

Review 8.  From cell biology to immunology: Controlling metastatic progression of cancer via microRNA regulatory networks.

Authors:  Jae Hyon Park; Evropi Theodoratou; George A Calin; Jae Il Shin
Journal:  Oncoimmunology       Date:  2016-09-09       Impact factor: 8.110

Review 9.  Proteomics for understanding miRNA biology.

Authors:  Tai-Chung Huang; Sneha M Pinto; Akhilesh Pandey
Journal:  Proteomics       Date:  2012-12-27       Impact factor: 3.984

Review 10.  MYC and the art of microRNA maintenance.

Authors:  James N Psathas; Andrei Thomas-Tikhonenko
Journal:  Cold Spring Harb Perspect Med       Date:  2014-04-15       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.